Divozilimab

2254061-60-2

Immunology/Inflammation related

Immunology/Inflammation

Divozilimab (BCD-132), a humanized monoclonal antibody targeting CD20 (CD20), is utilized in multiple sclerosis research [1].

Cool pack

-20°C

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-08309PCP 0.1 mL

Ask

MBS8226110-01 15 nmol

Ask

MBS8226110-02 30 nmol

Ask

MBS8226110-03 5x 30 nmol

Ask

sc-401323-LAC 200 µL

Ask

HY-153384-01 5 mg

Ask